Aqua Bio Technology ASA (OSL:ABTEC)

Market Cap	77.28M
Revenue (ttm)	102.75M
Net Income (ttm)	-330.35M
Shares Out	108.84M
EPS (ttm)	-3.54
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,703
Average Volume	291,242
Open	0.7490
Previous Close	0.6950
Day's Range	0.6940 - 0.7490
52-Week Range	0.4620 - 3.9900
Beta	0.68
RSI	40.97
Earnings Date	Aug 27, 2025

About Aqua Bio Technology ASA

Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Oslo, Norway.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 37
• Stock Exchange: Oslo Børs
• Ticker Symbol: ABTEC

Financial Performance

In 2024, Aqua Bio Technology ASA's revenue was 107.17 million, an increase of 472.00% compared to the previous year's 18.74 million. Losses were -337.35 million, 1504.6% more than in 2023.